Is Behavioral Therapy Plus Antimuscarinic Better Than Drug Alone to Treat Overactive Bladder?

[摘要] Urinary incontinence affects more than 10 million Americans and accounts for billions of dollars annually in societal costs. Antimuscarinics and behavioral treatments are both safe and effective first-line treatments for urge incontinence. Most patients do not achieve complete continence with either therapy alone. Adding behavioral training to pharmacologic treatment is an appealing approach to improving outcomes and to possible discontinuation of drug therapy. Evidence for the efficacy of combination therapy over either treatment alone is scarce and inconclusive. Here we review 3 new journal articles that examine this controversy from different perspectives.

[学科分类] 基础医学